03347 TIGERMED

Watchlist

35.050
0.0000.00%

Pre-Opening Auction Dec 13 09:00 CST

30.32BMarket Cap28.47P/E (TTM)

About TIGERMED Company

The company is an industry-leading integrated biomedical R&D service platform, providing innovative R&D solutions spanning the full cycle for the global pharmaceutical and medical device industry. Through a comprehensive service system and top quality standards, we help the biomedical industry improve R&D efficiency, reduce R&D risks, ensure high-quality delivery of research projects, accelerate the marketization process of pharmaceutical products, and fulfill our promises to the industry and patients. The company is a contract research organization (CRO) focusing on providing professional services throughout the clinical trial process for new drug research and development. It provides comprehensive and comprehensive clinical research solutions for global pharmaceutical and medical device innovators, ensures research quality, reduces R&D risks, shortens R&D cycles, saves R&D expenses, and promotes the product marketization process, so that patients can use newer and better pharmaceuticals and medical products as soon as possible. The services provided by the company mainly include clinical trial technical services and clinical trial-related services and laboratory services. Corporate honors: Eli Lilly Global Supplier Award, MSD Supplier Outstanding Service Award, Top 10 Listed Chinese Pharmaceutical Companies with the Most Investment Value, etc.

Company Profile

Symbol03347

Company NameTIGERMED

ISINCNE1000040M1

Listing DateAug 7, 2020

Issue Price100.00

Shares Offered107.07M share(s)

FoundedDec 15, 2004

Registered AddressChina

Chairmanxiaoping ye

Secretarymeiyi weng

Audit InstitutionLixin Certified Public Accountants (Special General Partnership)

Company CategoryMainland registration of Mainland Individuals control

Registered OfficeRoom 2001-2010, 20th Floor, Building 8, No. 19, Jugong Road, Xixing Street, Binjiang District, Hangzhou, Zhejiang

Head Office and Principal Place of Business40th Floor, Dah Sing Finance Centre, 248 Queen's Road East, Wan Chai, Hong Kong

Fiscal Year Ends12-31

Employees9348

MarketHong Kong motherboard

Phone0571-28887227

Fax0571-88211196

Emailir@tigermedgrp.com

Websitehttp://www.tigermedgrp.com

BusinessServices: Technology development, technical consulting, transfer of results for pharmaceutical-related industry products and health-related industrial products, management and statistical analysis of clinical trial data, translation, information technology and business process outsourcing services such as data processing by undertaking service outsourcing, non-certified labor vocational skills training for adults, uncultural education and training for adults, collection, collation, storage and publication of talent supply and demand information, career introduction, and talent information consultation. (For projects requiring approval according to law, business activities can only be carried out after approval by relevant departments)

Company Executives

Name
Position
Salary

xiaoping ye
Chairman, Executive Director, Chairman of the Strategy Development Committee, Authorized Representative
2.92M

xiaochun cao
Executive Director, General Manager, Remuneration Committee Members
1.16M

hao wu
Co-President, Executive Director, Member of the Strategy Development Committee
2.61M

zengyu wen
Executive Vice President, Executive Director, Deputy General Manager, Chief Operating Officer, Nomination Committee Members
1.20M

qiyu liao
Independent Non-Executive Director, Chairman of the Audit Committee, Nomination Committee Members, Remuneration Committee Members
220.00K

huagang yuan
Independent Non-Executive Director, Remuneration Committee Chairman, Member of the Strategy Development Committee, Audit Committee Members
122.00K

yuwen liu
Independent Non-Executive Director, Chairman of the Nomination Committee, Member of the Strategy Development Committee, Audit Committee Members
--